Condition
Vascular Anomalies clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Vascular Anomalies clinical trials that are recruiting, at sites in 10 countries (most in United States (3), Australia (2), Argentina (1)). By phase: Phase 2 (4). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 10Countries
Newest Vascular Anomalies clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Trametinib for Ras/MAPK Pathway Vascular Anomalies in Kids and Teens | Phase 2 | Philadelphia, Pennsylvania | Recruiting | Apr 24, 2026 |
| Alpelisib for PIK3CA/TIE-2/TEK pathway vascular anomalies | Phase 2 | Philadelphia, Pennsylvania | Recruiting | Apr 22, 2026 |
| Treatment for PIK3CA-related overgrowth and malformations using RLY-2608 | Phase 2 | Phoenix, Arizona and 39 other locations | Recruiting | Jan 23, 2025 |
| Registry for Rare Diseases | — | Buenos Aires, Buenos Aires | Recruiting | Aug 27, 2024 |
| Targeted therapies for patients with vascular malformations | Phase 2 | Parkville, Victoria and 1 other locations | Recruiting | Aug 9, 2023 |
All recruiting trials (5)
-
Trametinib for Ras/MAPK Pathway Vascular Anomalies in Kids and Teens
This study tests whether trametinib can help children and young people with Ras/MAPK-driven vascular anomalies.
-
Alpelisib for PIK3CA/TIE-2/TEK pathway vascular anomalies
This study tests whether alpelisib can help children and young adults with specific vascular anomalies driven by PIK3CA/TIE-2/TEK pathways.
-
Treatment for PIK3CA-related overgrowth and malformations using RLY-2608
This study is testing a new treatment called RLY-2608 to see if it can help adults and children with PIK3CA-related overgrowth and malformations feel better.
-
Registry for Rare Diseases
This study is creating a detailed registry to collect information on rare diseases like amyloidosis and sarcoidosis to help improve how they are diagnosed and treated.
-
Targeted therapies for patients with vascular malformations
This study is testing new targeted treatments for patients with slow-flow and fast-flow vascular malformations to see if they work better than the usual therapies.
Related topics
Quick answers
How many Vascular Anomalies clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (3 trials), Australia (2 trials), Argentina (1 trial), Belgium (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.